会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Intermediates to 1,9-dihydroxyoctahydrophenanthrenes
    • 中间体至1,9-二羟基焦合氢离子
    • US4310529A
    • 1982-01-12
    • US218712
    • 1980-12-22
    • Thomas H. AlthuisCharles A. HarbertMichael R. JohnsonLawrence S. Melvin, Jr.
    • Thomas H. AlthuisCharles A. HarbertMichael R. JohnsonLawrence S. Melvin, Jr.
    • C07C41/22C07C41/26C07C43/225C07C43/23C07C45/45C07C45/54C07C45/61C07C45/67C07C45/68C07C45/71C07C45/73C07C49/747C07C49/755C07D211/32C07D213/30C07D213/50C07D317/22C07D317/72A61K31/44A61K31/445C07D213/55
    • C07D213/30C07C41/01C07C41/22C07C41/26C07C45/45C07C45/54C07C45/61C07C45/67C07C45/68C07C45/71C07C45/73C07C49/747C07C49/755C07D211/32C07D213/50C07D317/22C07D317/72C07C2101/14
    • Compounds of the formula ##STR1## wherein R.sub.1 is hydrogen, benzyl, benzoyl, alkanoyl of 1 to 5 carbon atoms or --CO--(CH.sub.2).sub.p --NR'R" wherein p is 0 or an integer from 1 to 4; each of R' and R" when taken individually is hydrogen or alkyl of 1 to 4 carbon atoms; R' and R" when taken together with the nitrogen to which they are attached form a 5- or 6-membered heterocyclic ring selected from piperidino, pyrrolo, pyrrolidino, morpholino and N-alkylpiperazino having from 1 to 4 carbon atoms in the alkyl group;R.sub.2 is selected from hydrogen, alkanoyl of 1 to 6 carbon atoms and benzoyl;R.sub.3 is selected from hydrogen, methyl and ethyl;R.sub.4 is selected from hydrogen, alkyl of 1 to 6 carbon atoms and benzyl;Z is selected from:(a) alkylene having from one to nine carbon atoms;(b) --(alk.sub.1).sub.m --X--(alk.sub.2).sub.n --wherein each of (alk.sub.1) and (alk.sub.2) is alkylene having from 1 to 9 carbon atoms, with the proviso that the summation of carbon atoms in (alk.sub.1) plus (alk.sub.2) is not greater than 9;m and n are each 0 or 1;X is selected from O, S, SO and SO.sub.2 ; andW is selected from hydrogen, methyl, pyridyl, piperidyl, phenyl, monochlorophenyl, monofluorophenyl and ##STR2## wherein W.sub.1 is selected from hydrogen, phenyl, monochlorophenyl and monofluorophenyl; a is an integer from 1 to 5 and b is 0 or an integer from 1 to 4, with the proviso that the sum of a and b is not greater than 5.Compounds I and II are useful as analgesics. Compound III is useful as an intermediate for the preparation of Compounds I and II. Intermediates for the preparation of I, II and III are disclosed. A process for the use of compounds I and II to produce analgesia is also described.
    • 其中R 1为氢,苄基,苯甲酰基,1至5个碳原子的烷酰基或-CO-(CH 2)p -NR'R“,其中p为0 或1到4的整数; 当单独使用时,R'和R“各自为氢或1至4个碳原子的烷基; 当与它们所连接的氮一起取代时,R'和R“与烷基中具有1至4个碳原子的5-或6-元杂环选自哌啶子基,吡咯烷基,吡咯烷子基,吗啉代和N-烷基哌嗪基 组; R 2选自氢,1至6个碳原子的烷酰基和苯甲酰基; R3选自氢,甲基和乙基; R4选自氢,1至6个碳原子的烷基和苄基; Z选自:(a)具有1至9个碳原子的亚烷基; (b) - (alk1)mX-(alk2)n - 其中(alk1)和(alk2)各自为具有1至9个碳原子的亚烷基,条件是(alk1)加(alk2) )不大于9; m和n分别为0或1; X选自O,S,SO和SO2; W选自氢,甲基,吡啶基,哌啶基,苯基,一氯苯基,一氟苯基和其中W1选自氢,苯基,一氯苯基和单氟苯基; a为1至5的整数,b为0或1至4的整数,条件是a和b之和不大于5.化合物I和II可用作止痛剂。 化合物III可用作制备化合物I和II的中间体。 公开了制备I,II和III的中间体。 还描述了使用化合物I和II产生止痛的方法。
    • 5. 发明授权
    • 1,9-Dihydroxyoctahydrophenanthrenes and intermediates therefor
    • 1,9-二羟基八氢菲和其中间体
    • US4268523A
    • 1981-05-19
    • US78476
    • 1979-09-24
    • Thomas H. AlthuisCharles A. HarbertMichael R. JohnsonLawrence S. Melvin, Jr.
    • Thomas H. AlthuisCharles A. HarbertMichael R. JohnsonLawrence S. Melvin, Jr.
    • C07C41/22C07C41/26C07C43/225C07C43/23C07C45/45C07C45/46C07C45/54C07C45/61C07C45/67C07C45/68C07C45/71C07C45/73C07C49/747C07C49/755C07C49/83C07D211/32C07D213/30C07D213/50C07D317/22C07D317/72A01N35/00C07C49/788
    • C07D213/30C07C41/01C07C41/22C07C41/26C07C45/45C07C45/46C07C45/54C07C45/61C07C45/67C07C45/68C07C45/71C07C45/73C07C49/747C07C49/755C07C49/83C07D211/32C07D213/50C07D317/22C07D317/72C07C2101/14C07C2103/26
    • Compounds of the formula ##STR1## wherein R.sub.1 is hydrogen, benzyl, benzoyl, alkanoyl of 1 to 5 carbon atoms or --CO--(CH.sub.2).sub.p --NR'R" wherein p is 0 or an integer from 1 to 4; each of R' and R" when taken individually is hydrogen or alkyl of 1 to 4 carbon atoms; R' and R" when taken together with the nitrogen to which they are attached form a 5- or 6-membered heterocyclic ring selected from piperidino, pyrollo, pyrrolidino, morpholino and N-alkylpiperazino having from 1 to 4 carbon atoms in the alkyl group;R.sub.2 is selected from hydrogen, alkanoyl of 1 to 6 carbon atoms and benzoyl;R.sub.3 is selected from hydrogen, methyl and ethyl;R.sub.4 is selected from hydrogen, alkyl of 1 to 6 carbon atoms and benzyl;Z is selected from:(a) alkylene having from one to nine carbon atoms;(b) -(alk.sub.1).sub.m -X-(alk.sub.2).sub.n - wherein each of (alk.sub.1) and (alk.sub.2) is alkylene having from 1 to 9 carbon atoms, with the proviso that the summation of carbon atoms in (alk.sub.1) plus (alk.sub.2) is not greater than 9;m and n are each 0 or 1;X is selected from O, S, SO and SO.sub.2 ; andW is selected from hydrogen, methyl, pyridyl, piperidyl, phenyl, monochlorophenyl, monofluorophenyl and ##STR2## wherein W.sub.1 is selected from hydrogen, phenyl, monochlorophenyl and monofluorophenyl; a is an integer from 1 to 5 and b is 0 or an integer from 1 to 4, with the proviso that the sum of a and b is not greater than 5.Compounds I and II are useful as analgesics. Compound III is useful as an intermediate for the preparation of Compounds I and II. Intermediates for the preparation of I, II and III are disclosed. A process for the use of compounds I and II to produce analgesia is also described.
    • 其中R1是氢,苄基,苯甲酰基,1至5个碳原子的烷酰基或-CO-(CH2)p-NR'R“,其中p是0或 1到4的整数; 当单独使用时,R'和R“各自为氢或1至4个碳原子的烷基; 当与它们所连接的氮一起取代时,R'和R“与烷基中具有1至4个碳原子的5-或6-元杂环选自哌啶子基,吡咯烷基,吡咯烷子基,吗啉代和N-烷基哌嗪基 组; R 2选自氢,1至6个碳原子的烷酰基和苯甲酰基; R3选自氢,甲基和乙基; R4选自氢,1至6个碳原子的烷基和苄基; Z选自:(a)具有1至9个碳原子的亚烷基; (b) - (alk1)mX-(alk2)n-其中(alk1)和(alk2)各自为具有1至9个碳原子的亚烷基,条件是(alk1)加(alk2) )不大于9; m和n分别为0或1; X选自O,S,SO和SO2; W选自氢,甲基,吡啶基,哌啶基,苯基,一氯苯基,一氟苯基和其中W1选自氢,苯基,一氯苯基和单氟苯基; a为1至5的整数,b为0或1至4的整数,条件是a和b之和不大于5.化合物I和II可用作止痛剂。 化合物III可用作制备化合物I和II的中间体。 公开了制备I,II和III的中间体。 还描述了使用化合物I和II产生止痛的方法。
    • 8. 发明授权
    • Intermediates to 1,9-dihydroxyoctahydrophenanthrenes
    • 中间体至1,9-二羟基焦合氢离子
    • US4310669A
    • 1982-01-12
    • US219319
    • 1980-12-22
    • Thomas H. AlthuisCharles A. HarbertMichael R. JohnsonLawrence S. Melvin, Jr.
    • Thomas H. AlthuisCharles A. HarbertMichael R. JohnsonLawrence S. Melvin, Jr.
    • C07C41/22C07C41/26C07C43/225C07C43/23C07C45/45C07C45/54C07C45/61C07C45/67C07C45/68C07C45/71C07C45/73C07C49/747C07C49/755C07D211/32C07D213/30C07D213/50C07D317/22C07D317/72C07D213/55C07D211/34
    • C07D213/30C07C41/01C07C41/22C07C41/26C07C45/45C07C45/54C07C45/61C07C45/67C07C45/68C07C45/71C07C45/73C07C49/747C07C49/755C07D211/32C07D213/50C07D317/22C07D317/72C07C2101/14
    • Compounds of the formula ##STR1## wherein R.sub.1 is hydrogen, benzyl, benzoyl, alkanoyl of 1 to 5 carbon atoms or --CO--(CH.sub.2).sub.p --NR'R" wherein p is 0 or an integer from 1 to 4; each of R' and R" when taken individually is hydrogen or alkyl of 1 to 4 carbon atoms; R' and R" when taken together with the nitrogen to which they are attached form a 5- or 6-membered heterocyclic ring selected from piperidino, pyrrolo, pyrrolidino, morpholino and N-alkylpiperazino having from 1 to 4 carbon atoms in the alkyl group;R.sub.2 is selected from hydrogen, alkanoyl of 1 to 6 carbon atoms and benzoyl;R.sub.3 is selected from hydrogen, methyl and ethyl;R.sub.4 is selected from hydrogen, alkyl of 1 to 6 carbon atoms and benzyl;Z is selected from:(a) alkylene having from one to nine carbon atoms;(b) -(alk.sub.1).sub.m -X-(alk.sub.2).sub.n - wherein each of (alk.sub.1) and (alk.sub.2) is alkylene having from 1 to 9 carbon atoms, with the proviso that the summation of carbon atoms in (alk.sub.1) plus (alk.sub.2) is not greater than 9;m and n are each 0 or 1;X is selected from O, S, SO and SO.sub.2 ; andW is selected from hydrogen, methyl, pyridyl, piperidyl, phenyl, monochlorophenyl, monofluorophenyl and ##STR2## from hydrogen, phenyl, monochlorophenyl and monofluorophenyl; a is an integer from 1 to 5 and b is 0 or an integer from 1 to 4, with the proviso that the sum of a and b is not greater than 5.Compounds I and II are useful as analgesics. Compound III is useful as an intermediate for the preparation of Compounds I and II. Intermediates for the preparation of I, II and III are disclosed. A process for the use of Compounds I and II to produce analgesia is also described.
    • 其中R 1为氢,苄基,苯甲酰基,1至5个碳原子的烷酰基或-CO-(CH 2)p -NR'R“,其中p为0或1至 4; 当单独使用时,R'和R“各自为氢或1至4个碳原子的烷基; 当与它们所连接的氮一起取代时,R'和R“与烷基中具有1至4个碳原子的5-或6-元杂环选自哌啶子基,吡咯烷基,吡咯烷子基,吗啉代和N-烷基哌嗪基 组; R 2选自氢,1至6个碳原子的烷酰基和苯甲酰基; R3选自氢,甲基和乙基; R4选自氢,1至6个碳原子的烷基和苄基; Z选自:(a)具有1至9个碳原子的亚烷基; (b) - (alk1)mX-(alk2)n-其中(alk1)和(alk2)各自为具有1至9个碳原子的亚烷基,条件是(alk1)加(alk2) )不大于9; m和n分别为0或1; X选自O,S,SO和SO2; W选自氢,甲基,吡啶基,哌啶基,苯基,一氯苯基,一氟苯基和氢,苯基,一氯苯基和单氟苯基; a为1至5的整数,b为0或1至4的整数,条件是a和b之和不大于5.化合物I和II可用作止痛剂。 化合物III可用作制备化合物I和II的中间体。 公开了制备I,II和III的中间体。 还描述了使用化合物I和II产生镇痛的方法。
    • 9. 发明授权
    • 1,9-Dihydroxyoctahydrophenanthrenes and intermediates therefor
    • 1,9-二羟基八氢菲和其中间体
    • US4268692A
    • 1981-05-19
    • US78475
    • 1979-09-24
    • Thomas H. AlthuisCharles A. HarbertMichael R. JohnsonLawrence S. Melvin, Jr.
    • Thomas H. AlthuisCharles A. HarbertMichael R. JohnsonLawrence S. Melvin, Jr.
    • C07C41/22C07C41/26C07C43/225C07C43/23C07C45/45C07C45/46C07C45/54C07C45/61C07C45/67C07C45/68C07C45/71C07C45/73C07C49/747C07C49/755C07C49/83C07D211/32C07D213/30C07D213/50C07D317/22C07D317/72C07C49/733C07C69/78
    • C07D213/30C07C41/01C07C41/22C07C41/26C07C45/45C07C45/46C07C45/54C07C45/61C07C45/67C07C45/68C07C45/71C07C45/73C07C49/747C07C49/755C07C49/83C07D211/32C07D213/50C07D317/22C07D317/72C07C2101/14C07C2103/26
    • Compounds of the formula ##STR1## wherein R.sub.1 is hydrogen, benzyl, benzoyl, alkanoyl of 1 to 5 carbon atoms or --CO--(CH.sub.2).sub.p --NR'R" wherein p is 0 or an integer from 1 to 4; each of R' and R" when taken individually is hydrogen or alkyl of 1 to 4 carbon atoms; R' and R" when taken together with the nitrogen to which they are attached form a 5- or 6-membered heterocyclic ring selected from piperidino, pyrollo, pyrrolidino, morpholino and N-alkylpiperazino having from 1 to 4 carbon atoms in the alkyl group;R.sub.2 is selected from hydrogen, alkanoyl of 1 to 6 carbon atoms and benzoyl;R.sub.3 is selected from hydrogen, methyl and ethyl;R.sub.4 is selected from hydrogen, alkyl of 1 to 6 carbon atoms and benzyl;Z is selected from:(a) alkylene having from one to nine carbon atoms;(b) -(alk.sub.1).sub.m -X-(alk.sub.2).sub.n -wherein each of (alk.sub.1) and (alk.sub.2) is alkylene having from 1 to 9 carbon atoms, with the proviso that the summation of carbon atoms in (alk.sub.1) plus (alk.sub.2) is not greater than 9;m and n are each 0 or 1;X is selected from O, S, SO and SO.sub.2 ; andW is selected from hydrogen, methyl, pyridyl, piperidyl, phenyl, monochlorophenyl, monofluorophenyl and ##STR2## from hydrogen, phenyl, monochlorophenyl and monofluorophenyl; a is an integer from 1 to 5 and b is 0 or an integer from 1 to 4, with the proviso that the sum of a and b is not greater than 5.Compounds I and II are useful as analgesics. Compound III is useful as an intermediate for the preparation of Compounds I and II. Intermediates for the preparation of I, II and III are disclosed. A process for the use of compounds I and II to produce analgesia is also described.
    • 其中R 1为氢,苄基,苯甲酰基,1至5个碳原子的烷酰基或-CO-(CH 2)p -NR'R“,其中p为0或从 1至4; 当单独使用时,R'和R“各自为氢或1至4个碳原子的烷基; 当与它们所连接的氮一起取代时,R'和R“与烷基中具有1至4个碳原子的5-或6-元杂环选自哌啶子基,吡咯烷基,吡咯烷子基,吗啉代和N-烷基哌嗪基 组; R 2选自氢,1至6个碳原子的烷酰基和苯甲酰基; R3选自氢,甲基和乙基; R4选自氢,1至6个碳原子的烷基和苄基; Z选自:(a)具有1至9个碳原子的亚烷基; (b) - (alk1)mX-(alk2)n - 其中(alk1)和(alk2)各自为具有1至9个碳原子的亚烷基,条件是(alk1)加(alk2) )不大于9; m和n分别为0或1; X选自O,S,SO和SO2; W选自氢,甲基,吡啶基,哌啶基,苯基,一氯苯基,一氟苯基和氢,苯基,一氯苯基和单氟苯基; a为1至5的整数,b为0或1至4的整数,条件是a和b之和不大于5.化合物I和II可用作止痛剂。 化合物III可用作制备化合物I和II的中间体。 公开了制备I,II和III的中间体。 还描述了使用化合物I和II产生止痛的方法。